These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 643319)

  • 41. Calcineurin immunoreactivity in striatonigral degeneration.
    Goto S; Hirano A; Rojas-Corona RR
    Acta Neuropathol; 1989; 78(1):65-71. PubMed ID: 2544073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease.
    Eidelberg D; Takikawa S; Moeller JR; Dhawan V; Redington K; Chaly T; Robeson W; Dahl JR; Margouleff D; Fazzini E
    Ann Neurol; 1993 May; 33(5):518-27. PubMed ID: 8498828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple system atrophy: a review of 203 pathologically proven cases.
    Wenning GK; Tison F; Ben Shlomo Y; Daniel SE; Quinn NP
    Mov Disord; 1997 Mar; 12(2):133-47. PubMed ID: 9087971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathology of Shy-Drager syndrome.
    Sung JH; Mastri AR; Segal E
    J Neuropathol Exp Neurol; 1979 Jul; 38(4):353-68. PubMed ID: 448397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Type of familial extrapyramidal disease--cortico-striato-pallido-nigral degeneration (author's transl)].
    Maeda S; Yokoi S; Isaka K; Numabe T
    Seishin Shinkeigaku Zasshi; 1973 Oct; 75(10):657-72. PubMed ID: 4798818
    [No Abstract]   [Full Text] [Related]  

  • 47. 5-HT1B receptor binding in degenerative movement disorders.
    Castro ME; Pascual J; Romón T; Berciano J; Figols J; Pazos A
    Brain Res; 1998 Apr; 790(1-2):323-8. PubMed ID: 9593971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy.
    Pillon B; Gouider-Khouja N; Deweer B; Vidailhet M; Malapani C; Dubois B; Agid Y
    J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):174-9. PubMed ID: 7876847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Rare extrapyramidal disorders: progressive supranuclear paralysis and striato-nigral degeneration].
    Marttila R; Kalimo H; Nikoskelainen E; Rinne UK
    Duodecim; 1982; 98(3):191-200. PubMed ID: 7060514
    [No Abstract]   [Full Text] [Related]  

  • 50. Striatonigral degeneration, Alzheimer's disease, and inflammatory changes.
    Trotter JL
    Neurology; 1973 Nov; 23(11):1211-6. PubMed ID: 4795740
    [No Abstract]   [Full Text] [Related]  

  • 51. FLAIR MRI of striatonigral degeneration.
    Block SA; Bakshi R
    Neurology; 2001 May; 56(9):1200. PubMed ID: 11342686
    [No Abstract]   [Full Text] [Related]  

  • 52. Increased basal ganglia iron in striatonigral degeneration: in vivo estimation with magnetic resonance.
    Martin WR; Roberts TE; Ye FQ; Allen PS
    Can J Neurol Sci; 1998 Feb; 25(1):44-7. PubMed ID: 9532280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple system atrophy.
    Quinn N; Wenning G
    Br J Hosp Med; 1994 May 4-17; 51(9):492-4. PubMed ID: 7921508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Striato-nigral degeneration and Shy-Drager syndrome (idiopathic orthostatic hypotension).
    Vuia O
    Clin Neurol Neurosurg; 1975; 78(3):196-203. PubMed ID: 1231971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The striatonigral degenerations. Putaminal pigments and nosology.
    Borit A; Rubinstein LJ; Urich H
    Brain; 1975 Mar; 98(1):101-12. PubMed ID: 1122370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson's Disease Stages?
    Hopes L; Grolez G; Moreau C; Lopes R; Ryckewaert G; Carrière N; Auger F; Laloux C; Petrault M; Devedjian JC; Bordet R; Defebvre L; Jissendi P; Delmaire C; Devos D
    PLoS One; 2016; 11(4):e0147947. PubMed ID: 27035571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Striatonigral degeneration disputed in familial disorder.
    Nielsen SL
    Neurology; 1977 Mar; 27(3):306. PubMed ID: 557771
    [No Abstract]   [Full Text] [Related]  

  • 58. Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease--a retrospective comparison.
    Magalhães M; Wenning GK; Daniel SE; Quinn NP
    Acta Neurol Scand; 1995 Feb; 91(2):98-102. PubMed ID: 7785431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calbindin-D28k in the basal ganglia of patients with parkinsonism.
    Ito H; Goto S; Sakamoto S; Hirano A
    Ann Neurol; 1992 Oct; 32(4):543-50. PubMed ID: 1456738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Striatopallidonigral degeneration in Pick's disease: a clinicopathological study of 41 cases.
    Kosaka K; Ikeda K; Kobayashi K; Mehraein P
    J Neurol; 1991 Jun; 238(3):151-60. PubMed ID: 1869891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.